PTC Therapeutics

PTC Therapeutics is a global biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small molecule drugs targeting an area of RNA biology they refer to as post-transcription control.

Research focus: Stop Codon Readthrough.

Status:  Clinical.  Conditional approval in the EU.

Website: https://www.ptcbio.com/en/